WaveLight® Refractive Myopic Study

A Prospective, Global, Multi-Center Study for the Evaluation of Outcomes on Subjects Undergoing Myopic Treatments Using the WaveLight® Refractive Suite

The purpose of this study is to evaluate outcomes of subjects undergoing myopic surgery using the WaveLight® Refractive Suite (Excimer EX500 and Femtosecond FS200 lasers).

Study Overview

• Status: Completed
• Conditions: Refractive Error
• Intervention / Treatment: Device: Wavelight® Refractive Suite; Procedure: LASIK surgery

• Study Type: Interventional
• Enrollment (Actual): 104
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Willing and able to understand and sign an informed consent form.
• Have refractive error (in both eyes) that requires refractive surgery.
• Willing to undergo LASIK surgery using the Wavelight® Refractive Suite.
• Myopia between 0.00 to -12.0 diopters pre-operatively.
• Astigmatism between 0.00 to +6.00 diopters pre-operatively.
• Willing and able to attend post-operative examinations per protocol schedule.
• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Participation in a clinical study within the last 30 days.
• History of previous corneal surgery in either eye.
• Multifocal ablations in either eye.
• PRK or PTK surgery in either eye.
• Suffering from acute or recurring eye diseases in either eye, such as corneal ulcers, cataract, etc.
• Any ocular disease and/or condition that, in the Investigator's clinical judgment, may put subject at significant risk, compromise study results, or interfere significantly with subject's participation in the study.
• Unable to discontinue contact lens wear as specified in protocol.
• History of Herpes simplex or Herpes zoster keratitis.
• Active ocular rosacea.
• Lyme disease.
• History of dry eye that is unresponsive to treatment.
• Severe ocular allergies.
• Other medical conditions and use of medications as specified in protocol.
• Pregnant or planning to become pregnant during the study.
• Other protocol-specified exclusion criteria may apply.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: WaveLight Refractive Suite; LASIK surgery (laser in situ keratomileusis) per standard of care	Device: Wavelight® Refractive Suite; Excimer EX500 and Femtosecond FS200 lasers (Wavelight® Refractive Suite) used during LASIK surgery for corneal flap creation and corneal ablation; Procedure: LASIK surgery; Surgical procedure for treating refractive error based on corneal reshaping

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Least Squares Mean Difference in Binocular UCVA at 1 Month Post-Treatment and Pre-Treatment Binocular BCVA	Visual acuity (VA) with corrective devices (BCVA) was assessed binocularly (both eyes together) pre-treatment and subtracted from VA without spectacles or other visual corrective devices (UCVA) assessed binocularly at 1 month post-treatment. VA was measured at a distance of 4 meters and reported in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A negative value indicates an improvement in VA from pre-treatment to Month 1.	Month 1

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Mean Difference Between Achieved and Target Corneal Flap Thickness as Assessed by OCT	The expected flap thickness as determined pre-operatively was subtracted from the achieved flap thickness as assessed by optical coherence tomography (OCT) (ie, an imaging method using light to capture three-dimensional images). A positive number represents a postoperative flap thickness that is thicker than the expected flap thickness and vice versa for a negative number.	Operation/Surgery (Day 1), Month 1 Postoperative, Month 6 Postoperative
Mean Manifest Refraction (Sphere)	Manifest refraction was performed under photopic lighting conditions using an Early Treatment Diabetic Retinopathy Study (ETDRS) chart at 4 meters. The subject was manually refracted to his/her best correction using a phoropter. Each eye individually contributed to the mean.	Baseline (Day 0), Operation/Surgery (Day 1), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative
Mean Manifest Refraction (Cylinder)	Manifest refraction was performed under photopic lighting conditions using an ETDRS chart at 4 meters. The subject was manually refracted to his/her best correction using a phoropter. Each eye individually contributed to the mean.	Baseline (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative
Mean Laser Treatment Time	Treatment time with Excimer EX500 and Femtosecond FS200 lasers, measured in seconds.	Day 0 (surgery)
Mean Total Laser Treatment Time	Total treatment time with Excimer EX500 and Femtosecond FS200 lasers, measured in seconds. Total duration for both eyes was calculated as sum of duration for the right eye and left eye.	Day 0 (surgery)
Mean Response: "Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses"	As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error, on a scale from 0 (completely blind) to 10 (perfect vision).	Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative
Percent Response by Category: "In the Past 4 Weeks, to See Far Away, I Wore..."	As recorded by the subject on the RSVP questionnaire, where n/a means no use of glasses or contact lenses.	Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative
Percent Response by Category: "I Worry About my Vision"	As recorded by the subject on the RSVP questionnaire	Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative
Percent Response by Category: "My Vision Is a Concern in My Daily Life"	As recorded by the subject on the RSVP questionnaire	Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative
Percent Response by Category: "Driving at Night"	As recorded by the subject on the RSVP questionnaire, where 0 is "Not applicable", 1 is "No difficulty at all", 2 is "A little difficulty", 3 is "Moderate difficulty", 4 is "Severe difficulty" and 5 is "So much difficulty that I did not do the activity with this alternative".	Baseline (Day 0), Month 1 Postoperative, Month 6 Postoperative
Mean Contrast Sensitivity (CS)	Contrast sensitivity (ie, the ability to detect slight changes in luminance before they become indistinguishable) was assessed binocularly with distance manifest correction in place and uncorrected. Contrast sensitivity was assessed at spatial frequencies of 3, 6, 12, and 18 cycles per degree (cpd), where 3.0 cpd = A, 6.0 cpd = B, 12.0 cpd = C, and 18.0 cpd = D. Raw scores were log transformed. A higher numeric value represents better contrast sensitivity.	Baseline (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative
Wavefront Aberrometry	Wavefront aberrations (optical imperfections of the eye that prevent light from focusing perfectly on the retina, resulting in defects in the visual image) were measured using a commercially available system. Higher order aberrations (i.e., spherical aberrations, coma, and trifoil) are defined as optical imperfections which cannot be corrected by any reliable means of present technology.	Baseline (Day 0), Month 6 Postoperative
Corneal Curvature as Measured by Keratometry	Corneal curvature was assessed by a commercially available system and measured in diopters.	Baseline (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative

Collaborators and Investigators

• Sponsor: Alcon Research
• Investigators: Study Director: Clinical Manager, GMA, Surgical, Alcon Research

Study record dates

Study Major Dates

• Study Start: September 1, 2013
• Primary Completion (Actual): January 1, 2014
• Study Completion (Actual): August 1, 2014

Study Registration Dates

• First Submitted: September 10, 2013
• First Submitted That Met QC Criteria: September 10, 2013
• First Posted (Estimate): September 13, 2013

Study Record Updates

• Last Update Posted (Estimate): November 3, 2015
• Last Update Submitted That Met QC Criteria: October 2, 2015
• Last Verified: October 1, 2015

More Information

Terms related to this study

• Keywords: LASIK; astigmatism; refractive surgery; nearsighted; farsighted; WaveLight
• Additional Relevant MeSH Terms: Eye Diseases; Refractive Errors
• Other Study ID Numbers: A01353